Journal of Cardiac Failure
Volume 15, Issue 9 , Pages 775-781 , November 2009

Role of Ischemic Preconditioning and Inflammatory Response in the Development of Malignant Ventricular Arrhythmias After Reperfused ST-Elevation Myocardial Infarction

  • Hidehiro Kaneko, MD

      Affiliations

    • Division of Cardiology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
    • ,
  • Toshihisa Anzai, MD, FACC

      Affiliations

    • Division of Cardiology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
    • Corresponding Author InformationCorrespondence to: Toshihisa Anzai, MD, Division of Cardiology, Department of Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan. Tel: +81-3-5363-3793; Fax: +81-3-3353-2502.
    • ,
  • Kotaro Naito, MD

      Affiliations

    • Division of Cardiology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
    • ,
  • Takashi Kohno, MD

      Affiliations

    • Division of Cardiology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
    • ,
  • Yuichiro Maekawa, MD

      Affiliations

    • Division of Cardiology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
    • ,
  • Toshiyuki Takahashi, MD

      Affiliations

    • Division of Cardiology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
    • ,
  • Akio Kawamura, MD

      Affiliations

    • Division of Cardiology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
    • ,
  • Tsutomu Yoshikawa, MD, FACC

      Affiliations

    • Division of Cardiology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
    • ,
  • Satoshi Ogawa, MD, FACC

      Affiliations

    • Division of Cardiology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan

Received 16 January 2009 ,Revised 8 April 2009 ,Accepted 4 May 2009.

References 

  1. Lowel H, Dobson A, Keil U, Herman B, Hobbs MS, Stewart A, et al. Coronary heart disease case fatality in four countries. A community study. The Acute Myocardial Infarction Register Teams of Auckland, Augsburg, Bremen, FINMONICA, Newcastle, and Perth. Circulation. 1993;88:2524–2531
  2. O'Doherty M, Tayler DI, Quinn E, Vincent R, Chamberlain DA. Five hundred patients with myocardial infarction monitored within one hour of symptoms. Br Med J (Clinical Research ed). 1983;286:1405–1408
  3. Takahashi T, Anzai T, Yoshikawa T, Asakura Y, Ishikawa S, Mitamura H, et al. Absence of preinfarction angina is associated with a risk of no-reflow phenomenon after primary coronary angioplasty for a first anterior wall acute myocardial infarction. Int J Cardiol. 2000;75:253–260
  4. Takahashi T, Anzai T, Yoshikawa T, Maekawa Y, Asakura Y, Satoh T, et al. Effect of preinfarction angina pectoris on ST-segment resolution after primary coronary angioplasty for acute myocardial infarction. Am J Cardiol. 2002;90:465–469
  5. Kharbanda RK, Peters M, Walton B, Kattenhorn M, Mullen M, Klein N, et al. Ischemic preconditioning prevents endothelial injury and systemic neutrophil activation during ischemia-reperfusion in humans in vivo. Circulation. 2001;103:1624–1630
  6. Beauchamp P, Richard V, Tamion F, Lallemand F, Lebreton JP, Vaudry H, et al. Protective effects of preconditioning in cultured rat endothelial cells: effects on neutrophil adhesion and expression of ICAM-1 after anoxia and reoxygenation. Circulation. 1999;100:541–546
  7. Newby KH, Thompson T, Stebbins A, Topol EJ, Califf RM, Natale A. Sustained ventricular arrhythmias in patients receiving thrombolytic therapy: incidence and outcomes. The GUSTO Investigators. Circulation. 1998;98:2567–2573
  8. Anzai T, Yoshikawa T, Asakura Y, Abe S, Akaishi M, Mitamura H, et al. Preinfarction angina as a major predictor of left ventricular function and long-term prognosis after a first Q wave myocardial infarction. Journal of the American College of Cardiology. 1995;26:319–327
  9. Anzai T, Yoshikawa T, Shiraki H, Asakura Y, Akaishi M, Mitamura H, et al. C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction. Circulation. 1997;96:778–784
  10. Takahashi T, Anzai T, Yoshikawa T, Maekawa Y, Asakura Y, Satoh T, et al. Serum C-reactive protein elevation in left ventricular remodeling after acute myocardial infarction-role of neurohormones and cytokines. Int J Cardiol. 2003;88:257–265
  11. Maekawa Y, Anzai T, Yoshikawa T, Asakura Y, Takahashi T, Ishikawa S, et al. Prognostic significance of peripheral monocytosis after reperfused acute myocardial infarction: a possible role for left ventricular remodeling. J Am Coll Cardiol. 2002;39:241–246
  12. Shiraki H, Yoshikawa T, Anzai T, Negishi K, Takahashi T, Asakura Y, et al. Association between preinfarction angina and a lower risk of right ventricular infarction. N Engl J Med. 1998;338:941–947
  13. Killip T, Kimball JT. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol. 1967;20:457–464
  14. Forrester JS, Diamond G, Chatterjee K, Swan HJ. Medical therapy of acute myocardial infarction by application of hemodynamic subsets (first of two parts). N Engl J Med. 1976;295:1356–1362
  15. Adgey AA, Allen JD, Geddes JS, James RG, Webb SW, Zaidi SA, et al. Acute phase of myocardial infarction. Lancet. 1971;2:501–504
  16. Volpi A, Cavalli A, Santoro L, Negri E. Incidence and prognosis of early primary ventricular fibrillation in acute myocardial infarction—results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2) database. Am J Cardiol. 1998;82:265–271
  17. Matsumura K, Jeremy RW, Schaper J, Becker LC. Progression of myocardial necrosis during reperfusion of ischemic myocardium. Circulation. 1998;97:795–804
  18. Arai M, Lefer DJ, So T, DiPaula A, Aversano T, Becker LC. An anti-CD18 antibody limits infarct size and preserves left ventricular function in dogs with ischemia and 48-hour reperfusion. J Am Coll Cardiol. 1996;27:1278–1285
  19. Akar FG, Aon MA, Tomaselli GF, O'Rourke B. The mitochondrial origin of postischemic arrhythmias. J Clin Invest. 2005;115:3527–3535
  20. Ottani F, Galvani M, Ferrini D, Sorbello F, Limonetti P, Pantoli D, et al. Prodromal angina limits infarct size. A role for ischemic preconditioning. Circulation. 1995;91:291–297
  21. Iglesias-Garriz I, Corral F, Rodriguez MA, Garrote C, Montes M, Sevillano E. Pre-infarction angina elicits greater myocardial viability on reperfusion after myocardial infarction: a dobutamine stress echocardiographic study. J Am Coll Cardiol. 2001;37:1846–1850
  22. Papp R, Gonczi M, Kovacs M, Seprenyi G, Vegh A. Gap junctional uncoupling plays a trigger role in the antiarrhythmic effect of ischaemic preconditioning. Cardiovasc Res. 2007;74:396–405
  23. Hausenloy D, Wynne A, Duchen M, Yellon D. Transient mitochondrial permeability transition pore opening mediates preconditioning-induced protection. Circulation. 2004;109:1714–1717
  24. Itoh T, Fukami K, Suzuki T, Aoki H, Ohira K, Satoh N, et al. Effect of pre-myocardial infarction angina pectoris on post-myocardial infarction arrhythmias after reperfusion therapy. Am J Cardiol. 2006;97:1157–1161
  25. Anzai T, Yoshikawa T, Kaneko H, Maekawa Y, Iwanaga S, Asakura Y, et al. Association between serum C-reactive protein elevation and left ventricular thrombus formation after first anterior myocardial infarction. Chest. 2004;125:384–389
  26. Aronson D, Boulos M, Suleiman A, Bidoosi S, Agmon Y, Kapeliovich M, et al. Relation of C-reactive protein and new-onset atrial fibrillation in patients with acute myocardial infarction. Am J Cardiol. 2007;100:753–757
  27. London B, Baker LC, Lee JS, Shusterman V, Choi BR, Kubota T, et al. Calcium-dependent arrhythmias in transgenic mice with heart failure. Am J Physiol Heart Circ Physiol. 2003;284:H431–H441
  28. Lee SH, Chen YC, Chen YJ, Chang SL, Tai CT, Wongcharoen W, et al. Tumor necrosis factor-alpha alters calcium handling and increases arrhythmogenesis of pulmonary vein cardiomyocytes. Life Sci. 2007;80:1806–1815
  29. Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol. 2003;285:H579–H588
  30. Roberts R, DeMello V, Sobel BE. Deleterious effects of methylprednisolone in patients with myocardial infarction. Circulation. 1976;53:I204–I206
  31. Anzai T, Yoshikawa T, Takahashi T, Maekawa Y, Okabe T, Asakura Y, et al. Early use of beta-blockers is associated with attenuation of serum C-reactive protein elevation and favorable short-term prognosis after acute myocardial infarction. Cardiology. 2003;99:47–53
  32. De Sutter J, Tavernier R, De Buyzere M, Jordaens L, De Backer G. Lipid lowering drugs and recurrences of life-threatening ventricular arrhythmias in high-risk patients. J Am Coll Cardiol. 2000;36:766–772
  33. Chiu JH, Abdelhadi RH, Chung MK, Gurm HS, Marrouche NF, Saliba WI, et al. Effect of statin therapy on risk of ventricular arrhythmia among patients with coronary artery disease and an implantable cardioverter-defibrillator. Am J Cardiol. 2005;95:490–491

 Supported by the Global Center of Excellence (G-COE) Program at Keio University (H.K.) and the Medical School Faculty and Alumni Grant from Keio University Medical Science Fund (T.A.).

 No conflicts of interest exist in this study.

PII: S1071-9164(09)00143-2

doi: 10.1016/j.cardfail.2009.05.001

Journal of Cardiac Failure
Volume 15, Issue 9 , Pages 775-781 , November 2009

Article Tools

* Image Usage & Resolution